Ingrid Vášová

CD19 CAR T-Cell Therapy in Autoimmune Disease — A Case Series with Follow-up

Fabian Müller, Jule Taubmann, Laura Bucci et al. · New England Journal of Medicine · 2024 · 773 citations

Prognostic significance of maximum tumour (bulk) diameter in young patients with good-prognosis diffuse large-B-cell lymphoma treated with CHOP-like chemotherapy with or without rituximab: an exploratory analysis of the MabThera International Trial Group (MInT) study

Michael Pfreundschuh, Anthony D. Ho, Eva Cavallin‐Ståhl et al. · The Lancet Oncology · 2008 · 221 citations

Hematological Malignancy, Lymphoid Neoplasia, Maximum Tumour +9

Local immune effector cell-associated toxicity syndrome in CAR T-cell treated patients with autoimmune disease: an observational study

Melanie Hagen, Fabian Müller, Andreas Wirsching et al. · The Lancet Rheumatology · 2025 · 46 citations · Full text

Cardiopulmonary exercise testing in the evaluation of functional capacity after treatment of lymphomas in adults

Ingrid Vášová, Iva Tomášková, František Jedlička et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2006 · 37 citations

Treatment results of CHOP-21, CHOEP-21, MACOP-B and PMitCEBO with and without rituximab in young good-prognosis patients with aggressive lymphomas: Rituximab as an “equalizer” in the MInT (MABTHERA International Trial Group) study

M Pfreundschuh, Aloysius Ho, M Wolf et al. · Journal of Clinical Oncology · 2005 · 22 citations

Prognosis, Immunology, Blood 2004 +22